E. Bardou-jacquet, J. Morcet, G. Manet, F. Laine, M. Perrin et al., Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.682-689, 2015.
DOI : 10.1016/j.jhep.2014.10.025

URL : https://hal.archives-ouvertes.fr/hal-01091479

H. Zoller and A. Finkenstedt, Should C282Y homozygotes with mild iron overload be treated?, Journal of Hepatology, vol.62, issue.3, pp.510-511, 2015.
DOI : 10.1016/j.jhep.2014.11.037

N. Osborne, L. Gurrin, K. Allen, C. Constantine, M. Delatycki et al., HFE C282Y homozygotes are at increased risk of breast and colorectal cancer, Hepatology, vol.55, issue.4, pp.1311-1318, 2010.
DOI : 10.1002/hep.23448

J. Sullivan, Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis?, Circulation: Cardiovascular Genetics, vol.2, issue.6, pp.652-657, 2009.
DOI : 10.1161/CIRCGENETICS.109.906230

E. Bardou-jacquet, J. Morcet, G. Manet, F. Laine, M. Perrin et al., Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.682-689, 2015.
DOI : 10.1016/j.jhep.2014.10.025

URL : https://hal.archives-ouvertes.fr/hal-01091479

H. Zoller and A. Finkenstedt, Should C282Y homozygotes with mild iron overload be treated?, Journal of Hepatology, vol.62, issue.3, pp.510-511, 2015.
DOI : 10.1016/j.jhep.2014.11.037

J. Bircher, J. Benhamou, N. Mcintyre, M. Rizzetto, and J. Rodés, Oxford textbook of clinical hepatology, 1999.

H. Autorité and D. Santé, Management of patients with HFE-related haemochromatosis Available from: <http://www. has-sante.fr/portail/jcms/c_432802/en/management-of-patients-with-hfe-re- lated-haemochromatosis-type-1-haemochromatosis>, 2005.

B. Bacon, P. Adams, K. Kowdley, and L. Powell, Tavill ASAmerican Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the, Hepatology, vol.2011, pp.328-343, 2011.

C. Rennes, Service des maladies du foie, F-35033 Rennes, France INSERM